The European pain management devices market is estimated to grow at a CAGR of more than 7% during the forecast period. In the majority of the countries across Europe the average age of the population is increased considerably from the past years. As the average age of the population in the region increases, the prevalence of joint pain and other types of acute and chronic pain is expected to increase in the region, which is expected to increase the demand of the pain management devices in the region in the near future.

Visit for Global Pain Management Devices Market Report at: https://www.omrglobal.com/industry-reports/pain-management-devices-market

Moreover, in many countries of Europe, obesity is increasing at a considerable rate. This can be attributed to the shifting trend of eating habits in the region. Furthermore, mortality due to cancer has also increased considerably in the European region, this signifies the increasing prevalence of cancer in the region. This, in turn, is expected to have increased demand for the pain management devices used after the cancer treatment therapies such as chemotherapies.

The European pain management devices market is segmented on the basis of type and application. Based on type, the market is segmented into an analgesic infusion pump, ablation devices, and neurostimulators. Neurostimulators held the largest share in 2018. Neurostimulators can be used for the treatment of numerous conditions, such as post-surgical pain, Parkinson’s disease, low back pain, essential tremor and migraine, and muscle weakness. On the basis of application, the market is into cancer pain, neuropathic pain, musculoskeletal pain, facial and migraine pain and trauma. Neuropathic pain held the largest share in 2018.

Moreover, the report covers the analysis of several players operating in the European pain management devices market. Some of the major players include B. Braun Melsungen AG, Biomedical Research Ltd., Medtronic PLC, Abbot Laboratories Inc., Baxter International Inc., Becton, Dickinson and Company, Boston Scientific Corp., and others. In May 2018, Medtronic Plc announced that the US FDA granted premarket approval for its Deep Brain Stimulation therapy as adjunctive treatment to reduce the frequency of partial-onset seizures. The DBS therapy provides controlled electrical pulses to target in the brain known as the anterior nucleus of the thalamus.

Research Methodology

The market study of the European pain management devices market is incorporated by extensive primary and secondary research conducted by the research team at OMR.  Secondary research has been conducted to refine the available data to breakdown the market in various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior and macro-economic factors. Numbers extracted from Secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings authenticity to our reports.

Secondary Sources Include

• Financial reports of companies involved in the market.
• Authentic public databases such as the WHO, World Bank, and the National Institutes of Health.
• Whitepapers, research-papers, and news blogs.
• Company websites and their product catalog.

The report is intended for medical device companies, healthcare organizations, research institutes and academics, investing companies, potential investors, government organizations and regulatory agencies, and other market participants for overall market analysis and competitive analysis. The report provides an in-depth analysis of market size, different products, and future market opportunities. The report will serve as a source for a 360-degree analysis of the market thoroughly delivering insights into the market for making better business decisions.

Market Segmentation

1. European Pain Management Devices Market Research and Analysis by Type

2. European Pain Management Devices Market Research and Analysis by Application